New study confirms that engaging patients with digital self-monitoring in their treatment through myAir improves adherence ResMed today announced new European research from Price Waterhouse Coopers ...

SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD), the world’s leading health technology company focused on sleep, breathing, and care delivered in the home, today announced ...

ResMed’s myAir, a program for CPAP users to track sleep apnea treatment, is now available in the U.S. The app can be used by those working with the ResMed Air10. Courtesy of ResMed The web application ...

A new study from San Diego-based sleep monitoring company ResMed shows that patients on positive airway pressure (PAP) therapy for their sleep apnea are more likely to be compliant when they manage ...

For those who wear continuous positive airway pressure (CPAP) masks -- which help people with sleep apnea maintain steady, regular breathing while asleep – a new app is designed to help support device ...

Personal Therapy Assistant feature for AirSense 11 users, seen here within the myAir app SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- ResMed, a global leader in digital health and sleep apnea ...

SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has ...

Resmed believes its artificial intelligence-powered approach to personalizing the settings of its connected CPAP machines can lead to better sleep for people with obstructive apnea. Now the FDA has ...

Sleep Week (3/9-3/15) is a time to focus on getting better sleep for better health, but sleep apnea—a disorder where ...